ES2120962T3 - Composicion antivirica. - Google Patents

Composicion antivirica.

Info

Publication number
ES2120962T3
ES2120962T3 ES91910575T ES91910575T ES2120962T3 ES 2120962 T3 ES2120962 T3 ES 2120962T3 ES 91910575 T ES91910575 T ES 91910575T ES 91910575 T ES91910575 T ES 91910575T ES 2120962 T3 ES2120962 T3 ES 2120962T3
Authority
ES
Spain
Prior art keywords
composition
antiviral
present
antivirica
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91910575T
Other languages
English (en)
Inventor
Michael R Boyd
Paul A Cox
Gordon M Cragg
Peter M Blumberg
Nancy A Sharkey
Junichi Ishitoya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
US Department of Commerce
Original Assignee
US Department of Health and Human Services
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Department of Commerce filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2120962T3 publication Critical patent/ES2120962T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

UNA COMPOSICION ANTIVIRICA QUE COMPRENDE PROSTRATINA, UN DERIVADO DEL ESTER DE FORBOL, Y UN PORTADOR FARMACEUTICAMENTE ACEPTABLE, A LA VEZ QUE TIENE ACTIVIDAD ANTIVIRICA, NO TIENE ACTIVIDAD SUBSTANCIAL TUMORAL NI TIENE OTRAS PROPIEDADES TOXICOLOGICAS ADVERSAS SUBSTANCIALES QUE IMPEDIRIAN SU EMPLEO EN LA TERAPIA ANTIVIRICA. SE INCLUYEN LOS METODOS DE TRATAMIENTO DE LOS PACIENTES CON INFECCIONES VIRICAS.
ES91910575T 1990-05-30 1991-05-24 Composicion antivirica. Expired - Lifetime ES2120962T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53056290A 1990-05-30 1990-05-30

Publications (1)

Publication Number Publication Date
ES2120962T3 true ES2120962T3 (es) 1998-11-16

Family

ID=24114097

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91910575T Expired - Lifetime ES2120962T3 (es) 1990-05-30 1991-05-24 Composicion antivirica.

Country Status (10)

Country Link
US (1) US5599839A (es)
EP (1) EP0531413B1 (es)
JP (1) JPH0737380B2 (es)
AT (1) ATE170075T1 (es)
AU (1) AU639343B2 (es)
CA (1) CA2083945C (es)
DE (1) DE69130063T2 (es)
DK (1) DK0531413T3 (es)
ES (1) ES2120962T3 (es)
WO (1) WO1991018595A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1924548B1 (en) 2005-07-13 2018-03-28 Salvia Sciences, Inc. Ester prodrugs of prostratin and related phorbol compounds
US9533938B2 (en) 2007-01-31 2017-01-03 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters for the treatment of stroke
US9974764B2 (en) 2007-01-31 2018-05-22 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters in the treatment of neoplasms
ES2584327T3 (es) * 2007-01-31 2016-09-27 Biosuccess Biotech Company Composiciones y métodos de uso de ésteres de forbol
US10369222B2 (en) 2012-01-18 2019-08-06 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters for the treatment of stroke
US9636317B2 (en) 2007-01-31 2017-05-02 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters
US11564901B2 (en) 2007-01-31 2023-01-31 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters
US11696908B2 (en) 2007-01-31 2023-07-11 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters
US8067632B2 (en) 2007-07-26 2011-11-29 The Board Of Trustees Of The Leland Stanford Junior University Process to produce prostratin and structural or functional analogs thereof
EP2276478A4 (en) * 2008-04-11 2012-03-07 Aids Res Alliance METHOD FOR THE ADMINISTRATION OF PROSTRATIN AND STRUCTURAL ANALOGUE THEREOF
US20100298171A1 (en) * 2009-05-22 2010-11-25 Affymetrix, Inc. Apparatus for polymer synthesis
CN102724990A (zh) * 2009-07-29 2012-10-10 印第安纳大学研究及科技有限公司 药用植物的提取物及其应用
US9550722B2 (en) 2012-01-18 2017-01-24 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbal esters for the treatment of stroke
US10099996B2 (en) 2012-01-18 2018-10-16 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters in the treatment of neoplasms
ITUB20153575A1 (it) * 2015-09-11 2017-03-11 Fca Italy Spa "Sospensione per una ruota sterzante di autoveicolo, con asse di sterzo semi-virtuale"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902716A (en) * 1984-12-18 1990-02-20 Harbor Branch Oceanographic Institutuion, Inc. Anti-viral chamigrene derivatives

Also Published As

Publication number Publication date
EP0531413B1 (en) 1998-08-26
DK0531413T3 (da) 1999-05-25
DE69130063T2 (de) 1999-02-25
US5599839A (en) 1997-02-04
DE69130063D1 (de) 1998-10-01
AU639343B2 (en) 1993-07-22
AU7909991A (en) 1991-12-31
JPH0737380B2 (ja) 1995-04-26
CA2083945C (en) 1995-02-07
JPH05506451A (ja) 1993-09-22
ATE170075T1 (de) 1998-09-15
WO1991018595A1 (en) 1991-12-12
EP0531413A1 (en) 1993-03-17
EP0531413A4 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
ES2120962T3 (es) Composicion antivirica.
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
IT1256450B (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
BG102600A (en) Carbamoyloxy derivatives of mutilin and their use as bactericides
ATE87214T1 (de) Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
FI922325A (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
IE40860B1 (en) Substituted benzamides
ATE26216T1 (de) Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung.
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
HU907654D0 (en) Process for the production of medical preparations with increased stabilization, and without tissue-harming effect
NO890046D0 (no) Disubstituerte pyridiner.
FR2361404A1 (fr) Nouvelles 7-boxyiminoacylcephalosporines, leurs procedes de preparation et leur application en therapeutique
ATE76579T1 (de) Interferon-zusammensetzungen.
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
ES8607728A1 (es) Procedimiento de preparacion de una nueva composicion anti- biotica sinergetica, de uso veterinario
IT1239064B (it) Uso terapeutico del dipiridamolo
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
EP0459176A3 (en) Oligophosphates with antiviral activity
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
ATE210445T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
ES2051788T3 (es) Un producto farmaceutico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 531413

Country of ref document: ES